Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Provenge for Asymptomatic Metastatic Hormone-Refractory Prostate Cancer
NCT00005947Phase 3Completed
- Sponsor
- Dendreon
- Start
- Nov 1999
- Primary completion
- Sep 2004
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of sipuleucel-T in prostate cancer (PCa), sponsored by Dendreon. Started Nov 1999; status: completed.
02
Drugs
sipuleucel-T
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00005947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005947.